Biallelic variants in <i>ADARB1</i>, encoding a dsRNA-specific adenosine deaminase, cause a severe developmental and epileptic encephalopathy
Reza Maroofian(University College London), Henry Houlden(Queen Mary University of London), Marcello Scala(Hospital for Sick Children), Hamid Galehdari(Shahid Chamran University of Ahvaz), Mahmoud Y. Issa(National Research Centre), Liam P. Keegan(Central European Institute of Technology), Alireza Sedaghat(Ahvaz Jundishapur University of Medical Sciences), Jiří Sedmík(Central European Institute of Technology), Neda Mazaheri(Shahid Chamran University of Ahvaz), Reza Azizi Malamiri(Ahvaz Jundishapur University of Medical Sciences), Gholamreza Shariati(Ahvaz Jundishapur University of Medical Sciences), Peter Bauer(Centogene (Germany)), Mary A. O’Connell(Central European Institute of Technology), Christian Beetz(Jena University Hospital), Maha S. Zaki(National Water Research Center)
Cited by 30
Related Papers
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Mortality after surgery in Europe: a 7 day cohort study
|The Lancet|2012|1.4k
The RNA-Editing Enzyme ADAR1 Controls Innate Immune Responses to RNA
|Cell Reports|2014|675